US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 28 for "Toll-like receptor agonist-nanoparticle vaccine adjuvant" (California Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,173, issued on July 28, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Toll-like receptor agonist-nanoparticle vaccine adjuvant" was invented by Qian Yin (Los Altos, Calif.), Mark M. Davis (Atherton, Calif.), Wei Luo (Redwood City, Calif.) and Bali Pulendran (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods are provided relating to TLR agonist nanoparticle vaccine adjuvant formulations."

The patent was filed on April 20, 2022, under Application No. 18/287,444.

*For further information, including images, charts and tables, please visit: http://patft.usp...